EMA Authorised: Twinrix Adult (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

Twinrix Adult (hepatitis A virus inactivated + hepatitis B surface antigen) has been authorised for use in adults by the EMA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Twinrix Adult (Hepatitis A and Hepatitis B vaccine (inactivated))

Snippet

Status: Authorised. Therapeutic area: Hepatitis B;Hepatitis A;Immunization. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 29/07/2026